High flow nasal cannula (HFNC) is a relatively new non-invasive ventilation therapy that
seems to be well tolerated in children. Recently a marked increase in the use of HFNC has …

Background To assess the published evidence to establish the efficacy and safety of high
flow oxygen cannula (HFNC) as respiratory support for children up to 24 months of age with …

Background High-flow oxygen therapy through a nasal cannula has been increasingly used
in infants with bronchiolitis, despite limited high-quality evidence of its efficacy. The efficacy …

Aim Bronchiolitis is the most common lower respiratory tract disorder in infants aged less
than 12 months, and research has demonstrated that there is substantial variation in practice …

Objectives To examine the proportionate use of critical care resources among children of
differing medical complexity admitted to pediatric intensive care units (ICUs) in tertiary-care …

Objectives: To summarize the current literature describing high-flow nasal cannula use in
children, the components and mechanisms of action of a high-flow nasal cannula system …

BACKGROUND: Heated and humidified high-flow nasal cannula (HFNC) is a widely used
form of respiratory support; however, data regarding optimal flows for a given patient size or …

Respiratory syncytial virus (RSV) infection represents an excellent paradigm of precision
medicine in modern paediatrics and several clinical trials are currently performed in the …

Bronchiolitis represents the most common cause of non-elective admission to paediatric
intensive care units (ICUs). We assessed changes in admission rate, respiratory support …

OBJECTIVE: The goal of this study was to assess the association of the introduction of a
ward's high-flow nasal cannula (HFNC) guideline with clinical outcomes of infants with …